前往化源商城

Bioorganic & Medicinal Chemistry 2001-10-01

Structure-activity relationships and optimisation of the selective MDR modulator 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative.

S Dei, E Teodori, A Garnier-Suillerot, F Gualtieri, S Scapecchi, R Budriesi, A Chiarini

文献索引:Bioorg. Med. Chem. 9(10) , 2673-82, (2001)

全文:HTML全文

摘要

Several ring-substituted derivatives of previously studied MDR inhibitors 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl)pentanenitrile and 2-(3,4-dimethoxyphenyl)-5-[(9-fluorenyl)-N-methylamino]-2-(methylethyl)pentanenitrile have been synthesised and studied with the aim of optimising activity and selectivity. The results show that MDR inhibition is scarcely sensitive to modulation of the electronic properties of the fluorene ring. Even if dramatic improvement was not obtained, one of the compounds (2) showed improved potency and selectivity with respect to the leads and appears to be a better candidate for drug development.

相关化合物

结构式 名称/CAS号 全部文献
4-氨基-9-芴酮 结构式 4-氨基-9-芴酮
CAS:4269-15-2